The Endocrine Society is committed to improving awareness and understanding of endocrine-disrupting chemicals (EDCs) in the U.S. and globally. Since the 2009 release of its Scientifi c Statement on EDCs, the Society has advocated for more research on EDCs and for the endocrine perspective to be incorporated into chemical risk assessment paradigms. Because of the Society’s scientific expertise, it has been able to influence policy decisions and it has become recognized as a leading scientific organization in this area. In recent months, the Society has advanced its global agenda on EDCs through participation in the Strategic Approach to International Chemicals Management (SAICM), a global policy framework to protect people and the environment from hazardous chemicals. The Society also worked to ensure that the European Parliament takes the latest endocrine science into account as the European Union seeks to regulate EDCs.
You may also like
Endocrine Society Advocacy Updates
Endocrine Society Endorses Right to IVF Act In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…
August 2024 Endocrine Society Advocacy Update
Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…
Loading ...